LATEST NEWS   Malaysia awarded victory in Sepak Takraw World Cup team regu final after Thailand withdrew following protests over referee's decision | 

There are 100 news based on search keyword " pharmaceutical "

Curia Completes Aseptic Suites Upgrade In Valladolid

KUALA LUMPUR, May 20 (Bernama) -- Curia Global Inc (Curia), a global research, development and manufacturing organisation, has completed upgrades to its two aseptic suites in Valladolid as part of a US$4 million investment aligned with the European Union’s Good Manufacturing Practice (GMP) Annex 1 standards. (US$1=RM3.97)

Pharmaniaga Gets Approval For Five-For-One Share Consolidation

KUALA LUMPUR, May 19 (Bernama) -- Pharmaniaga Bhd today secured shareholder approval for its proposed five-for-one share consolidation at the group’s extraordinary general meeting (EGM), with completion expected in early June 2026.

Medisca, dsm-firmenich To Expand Vitamin APIs Access For US Market

KUALA LUMPUR, May 13 (Bernama) -- Medisca, a leader in personalised pharmaceutical medicine, has entered into a strategic partnership with dsm–firmenich to expand access to pharmaceutical-grade vitamin active pharmaceutical ingredients (APIs) for the United States (US) compounding market.

DHCG, KunTuo Sign China Clinical Trials Collaboration

KUALA LUMPUR, May 12 (Bernama) -- Dark Horse Consulting Group (DHCG) and KunTuo Medical Research and Development (Beijing) Co Ltd (KunTuo) signed a memorandum of understanding to establish a strategic collaboration supporting biotherapeutics developers conducting clinical trials in China.

Malaysia's Wholesale And Retail Trade Climbs 9.8 Pct To RM169 Bln In March 2026 -- DOSM

KUALA LUMPUR, May 11 (Bernama) -- Malaysia’s wholesale and retail trade climbed 9.8 per cent year-on-year in March 2026, with sales worth RM169 billion, supported by strong seasonal consumer demand, according to the Department of Statistics Malaysia (DOSM).

AGC Biologics Honoured For Leadership In Regulatory, Quality Compliance

KUALA LUMPUR, April 28 (Bernama) -- AGC Biologics, a global biopharmaceutical contract development and manufacturing organisation (CDMO), has won the 2026 Fierce Outsourcing Award for Leadership in Regulatory and Quality Compliance.

RegASK AI Platform Streamlines Regulatory Operations At CellCarta

KUALA LUMPUR, April 22 (Bernama) -- RegASK, the agentic artificial intelligence (AI) platform redefining regulatory intelligence, has announced the results of a year-long collaboration to modernise CellCarta’s regulatory intelligence operations.

Malaysia's Plastics Manufacturing Industry To Experience Continuous Volatiltiy -- MPMA

KUALA LUMPUR, April 17 (Bernama) -- The Malaysian Plastics Manufacturers Association (MPMA) expects the country’s plastics manufacturing industry to experience continued volatility in the near to medium term amid the West Asia crisis. 

Government Explores Alternatives For Medicine, Device Supply And Price Issues – Akmal Nasrullah

JOHOR BAHRU, April 11 (Bernama) -- The government will take intervention measures to address issues of supply and rising prices of medicines and medical devices, including exploring alternative sources of materials, following the global energy crisis.

Malaysia's Wholesale, Retail Trade Sales Rise 5.3 Pct To RM156.3 Bln In February -- DOSM

KUALA LUMPUR, April 10 (Bernama) -- Malaysia’s wholesale and retail trade in February 2026 recorded sales of RM156.3 billion, up 5.3 per cent year-on-year (y-o-y), according to the Department of Statistics Malaysia (DOSM).

MTEN Studying Steps To Diversify Fuel Input Sources Amid Global Energy Crisis - Akmal Nasrullah

KUALA LUMPUR, April 7 (Bernama) -- The National Economic Action Council (MTEN) has studied measures to diversify fuel input sources, strengthen strategic cooperation with key trading partners, and ensure the security of production inputs amid the global energy crisis.

Ekuinas Invests In Ain Medicare Via RM1 Bln Tranche IV Fund

KUALA LUMPUR, April 7 (Bernama) -- Ekuiti Nasional Bhd (Ekuinas) has invested in a bumiputera manufacturer of sterile parenteral pharmaceutical products Ain Medicare Sdn Bhd via Ekuinas’ RM1 billion Tranche IV fund.